Last update April 28, 2026

Mestranol + Chlormadinone

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Birth control pill that contains the combination of an estrogen (Mestranol) and a progestin (Cholrmadinone) for oral use.

MESTRANOL:

  • A latest up date no published data on excretion in breast milk, found were found. However, it is known that its metabolite Ethinylestradiol is excreted into milk in no or small amount.
  • There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol. It may reduce the protein content of the milk.
  • No problems have been observed in infants whose mothers were treated, except one isolated case of transient gynecomastia. (Curtis 1964)

CHLORMADINONE is a synthetic progestin that is similar to progesterone.

At the date of the last update we did not find any published data on its excretion in breast milk.

No changes in prolactin levels or alterations in milk production or composition have been observed in women treated with chlormadinone, except for a slight decrease in the amount of proteins.

Detailed information on chlormadinone, including references, can be found below under “Chlormadinone”

American Academy of Paediatrics: COCs are usually compatible with breastfeeding. (AAP 2001)

For a detailed discussion with references:

  • on why non-hormonal methods are the first choice during the first 4–6 weeks postpartum, followed by IUDs and progestin implants,
  • on the potential problems associated with the use of combined estrogen-progestin contraceptives,
  • the possible decrease in milk production with estrogen use,
  • and why progestin-only contraceptives are preferable during breastfeeding,

see below: “(Combined Estrogen + Progestin Contraceptives, COCs)”


See below the information of these related products:

  • (Combined oestrogen-progestogen contraceptives, COCs) (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Chlormadinone Acetate (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)
  • Ethinylestradiol (Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.)

Alternatives

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Mestranol + Chlormadinone belongs to this group or family:

Tradenames

Main tradenames from several countries containing Mestranol + Chlormadinone in its composition:

References

  1. AAP - American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 Sep;108(3):776-89. Abstract Full text (link to original source) Full text (in our servers)
  2. CURTIS EM. ORAL-CONTRACEPTIVE FEMINIZATION OF A NORMAL MALE INFANT: REPORT OF A CASE. Obstet Gynecol. 1964 Abstract

Total visits

15,106

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM